1Ruscheweyh R, Forsthuber L, Schoffnegger D, et al. Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adeha-, and C-fibers after chronic constriction injury in mice. J Comp Neurol,2007,502 : 325 336.
2Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol, 2006,17 : 592 - 604.
3Velazquez KT, Mohammad H, Sweitzer SM. Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res, 2007,55 : 578 -589.
4Prescott SA, Sejnowski TJ, De Koninck Y. Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain. Mol Pain, 2006,2 : 32.
5Scholz J, Broom DC, Youn DH, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci, 2005,25 : 7317 -7323.
6Przewlocki R, Przewlockal B. Opioids in neuropathic pain. Curr Pharm,2005,11 : 3013 - 3025.
7Xu M, Petraschka M, McLaughlin JP, et al. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci, 2004,24 : 4576 4584.
8Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev, 2008,32:972-983.
9Schafers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Rev Neurother, 2007,7 : 1613 - 1627.
10Bee LA, Dickenson AH. Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience, 2007,147 : 786 - 793.
